DANIELA DILLMAN: Open Payments
NPI 1316371842 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 14 payments from 8 companies in 2025. Trend: 2023 $626 · 2024 $525 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| PFIZER INC. | 2 | $38 |
| Boston Scientific Corporation | 1 | $31 |
| REVANCE THERAPEUTICS, INC. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: UBRELVY, AIRSUPRA, WaveWriter Alpha Prime 16, DAXXIFY, QULIPTA, REPATHA, PREVNAR 20, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
